Patent · US Active

Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease

US12012390B2 · kind B2 · utility

0Cited by

5References

19Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Song Feng · Shanghai, CN
Chungen Liang · Shanghai, CN
Yongfu Liu · Shanghai, CN
Hong Shen · Shanghai, CN
Xuefei Tan · Shanghai, CN
Jun Wu · Beijing, CN
Dongdong Chen · Hangzhou City, CN
Chao Li · Shanghai, CN
Li Wang · Shanghai, CN

Key dates

Filing date	Sep 11, 2019
Grant date	Jun 18, 2024
Priority date	—
Expiry date	Jun 21, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DMA) inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.